You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mucinous adenocarcinoma of the rectum

Showing 1 - 25 of 3,073
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Mucinous Adenocarcinoma of the Colon
  • Mucinous Adenocarcinoma of the Rectum
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 26, 2022

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

Active, not recruiting
  • Mucinous Adenocarcinoma of the Rectum
  • +7 more
  • bevacizumab
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 5, 2022

Mucinous Adenocarcinoma of the Rectum, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Rectum Trial in Richmond

Completed
  • Mucinous Adenocarcinoma of the Rectum
  • +9 more
  • intensity-modulated radiation therapy
  • +4 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Jul 19, 2021

Mucinous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Seoul (Bevacizumab + modified FOLFIRINOX)

Recruiting
  • Mucinous Ovarian Cancer
  • +2 more
  • Bevacizumab + modified FOLFIRINOX
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Dec 25, 2022

Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland

Not yet recruiting
  • Secondary Malignant Neoplasm of Retroperitoneum
  • +2 more
  • Intestinal, Multivisceral or Modified Multivisceral Transplantation
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023

Genetics of Appendix Cancer Study

Recruiting
  • Appendix Cancer
  • +14 more
  • Genetic profiling
  • Retrospective tissue procurement
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Feb 8, 2023

Rectal Cancer Trial in Detroit (Standard of care chemo with the change for avoidance of extensive surgery)

Recruiting
  • Rectal Cancer
  • Standard of care chemotherapy with the change for avoidance of extensive surgery
  • Detroit, Michigan
    Ascension St. John Hospital
Jan 30, 2023

Pseudomyxoma Peritonei, Peritoneal Cancer, Mucinous Adenocarcinoma Trial (Bromelain, Acetylcysteine, Interventional radiology

Not yet recruiting
  • Pseudomyxoma Peritonei
  • +3 more
  • (no location specified)
Feb 28, 2022

Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in Kaliningrad (Right hemicolectomy, Left hemicolectomy, Sigmoid colon

Recruiting
  • Colorectal Cancer
  • +5 more
  • Right hemicolectomy
  • +6 more
  • Kaliningrad, Kaliningrad Region, Russian Federation
    Baltic Federal University
Sep 15, 2023

Clinical, Histological and Prognostic Forms of Adenocarcinoma of

Active, not recruiting
  • Anal Adenocarcinoma
    • Paris, France
    • +1 more
    Nov 7, 2022

    Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

    Terminated
    • Ovarian Cancer
    • +21 more
    • Exercise Counseling
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 6, 2022

    Pancreatic Cyst, Pancreatic Tumors, Pancreatic Cancer Trial in San Francisco (Survey)

    Recruiting
    • Pancreatic Cyst
    • +7 more
    • Survey
    • San Francisco, California
      University of California, San Francisco
    Sep 20, 2022

    Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

    Not yet recruiting
    • Advanced Solid Tumor
    • +18 more
    • (no location specified)
    Aug 10, 2022

    Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)

    Terminated
    Has Results
    • Non-Metastatic Adenocarcinoma of the Rectum
    • Radiation Therapy
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 1, 2021

    Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

    Not yet recruiting
    • Colorectal Adenocarcinoma
    • +2 more
    • Trondheim, Trondelag, Norway
    • +2 more
    Aug 15, 2022

    Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

    Recruiting
    • Cervical Adenocarcinoma
    • +47 more
    • Bevacizumab
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Dec 5, 2022

    Liquid Biopsies and Tumor Molecular Profiling in Predicting

    Recruiting
    • Endometrial Clear Cell Adenocarcinoma
    • +5 more
    • Biospecimen Collection
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 3, 2022

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022

    Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma Trial in

    Recruiting
    • Recurrent Endometrial Adenocarcinoma
    • +8 more
    • Ipilimumab
    • Nivolumab
    • Iowa City, Iowa
    • +9 more
    Jan 27, 2023

    Peritoneal Cancer, Pseudomyxoma Peritonei, Mucinous Adenocarcinoma Trial in Lexington, Stony Brook (nanoliposomal irinotecan)

    Completed
    • Peritoneal Cancer
    • +7 more
    • nanoliposomal irinotecan
    • Lexington, Kentucky
    • +1 more
    May 5, 2022

    Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,

    Terminated
    • Rectal Mucinous Adenocarcinoma
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 21, 2022

    Mt-sDNA asSurveillance Procedure in Colorectal Cancer Survivors

    Not yet recruiting
    • Adenocarcinoma of the Colon
    • +4 more
      • Cleveland, Ohio
        University Hospitals Seidman Cancer Center, Case Comprehensive C
      Jan 30, 2023

      Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in

      Not yet recruiting
      • Stage I Testicular Seminoma
      • +13 more
      • Oncological Follow-up
      • Amiens, France
      • +2 more
      Aug 12, 2022

      Adenocarcinoma of the Pancreas, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Lyon (Pembrolizumab,

      Active, not recruiting
      • Adenocarcinoma of the Pancreas
      • +2 more
      • Lyon, France
        Centre Léon Bérard
      Mar 17, 2022

      Rectum Adenocarcinoma Trial in Paris, Saint-Cloud (Biopsy)

      Recruiting
      • Rectum Adenocarcinoma
      • Biopsy
      • Paris, Ile De France, France
      • +2 more
      Mar 30, 2022